CRHR1 antagonists have been proven to be effective in the alleviation of IBD via the blockade of colonic hypersensitivity induced by colonic inflammatory reactions, thus providing a novel therapeutic option for the treatment of stress-aggravated IBD [22, 36, 37, 39]. Here, CRHR1 is linked to inflammatory bowel disease.